Gene · 7439
Papers1,518
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,518
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a Complex Allele in IMPG2 as a Cause of Adult-Onset Vitelliform Macular Dystrophy. | Invest Ophthalmol Vis Sci | 2022 | 35608844 | PubTator, text mining | PubMed |
| First Pediatric Case of Autosomal Recessive Homozygotic Bestrophinopathy due to Homozygous Mutation c.187G>C p. in Two Brothers. | J Clin Med Res | 2022 | 35573931 | PubTator, text mining | PubMed |
| Clinical and genetic spectrums of 413 North African families with inherited retinal dystrophies and optic neuropathies. | Orphanet J Rare Dis | 2022 | 35551639 | PubTator, text mining | PubMed |
| Identification and Validation of Inflammatory Response-Related Gene Signatures to Predict the Prognosis of Neuroblastoma. | Int J Genomics | 2022 | 35535346 | PubTator, text mining | PubMed |
| Influence of effective polarization on ion and water interactions within a biomimetic nanopore. | Biophys J | 2022 | 35527400 | PubTator, text mining | PubMed |
| Dental applications of induced pluripotent stem cells and their derivatives. | Jpn Dent Sci Rev | 2022 | 35516907 | PubTator, text mining | PubMed |
| Retinal pigment epithelium melanin imaging using polarization-sensitive optical coherence tomography for patients with retinitis pigmentosa. | Sci Rep | 2022 | 35504937 | PubTator, text mining | PubMed |
| Revisiting the Role of Astrocytic MAOB in Parkinson's Disease. | Int J Mol Sci | 2022 | 35457272 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Screening of 43 Families with Non-Syndromic Early-Onset High Myopia: A Clinical and Genetic Study. | Int J Mol Sci | 2022 | 35457050 | PubTator, text mining | PubMed |
| Electrophysiology-Guided Genetic Characterisation Maximises Molecular Diagnosis in an Irish Paediatric Inherited Retinal Degeneration Population. | Genes (Basel) | 2022 | 35456422 | PubTator, text mining | PubMed |
| Human iPSC- and Primary-Retinal Pigment Epithelial Cells for Modeling Age-Related Macular Degeneration. | Antioxidants (Basel) | 2022 | 35453289 | PubTator, text mining | PubMed |
| Genetic Testing of Inherited Retinal Disease in Australian Private Tertiary Ophthalmology Practice. | Clin Ophthalmol | 2022 | 35444405 | PubTator, text mining | PubMed |
| The effect of docetaxel on retinal pigment epithelial cells. | Toxicol Rep | 2022 | 35433274 | PubTator, text mining | PubMed |
| Longitudinal Analysis of a Resolving Foveomacular Vitelliform Lesion in ABCA4 Disease. | Ophthalmol Retina | 2022 | 35413457 | PubTator, text mining | PubMed |
| Applying Protein-Protein Interactions and Complex Networks to Identify Novel Genes in Retinitis Pigmentosa Pathogenesis. | Int J Mol Sci | 2022 | 35409321 | PubTator, text mining | PubMed |
| Astrocytic Glutamatergic Transmission and Its Implications in Neurodegenerative Disorders. | Cells | 2022 | 35406702 | PubTator, text mining | PubMed |
| A Novel Mutation in the Membrane Frizzled-Related Protein Gene for Posterior Microphthalmia, Non-pigmented Retinitis Pigmentosa, Optic Nerve Drusen, and Retinoschisis in a Consanguineous Family. | Front Med (Lausanne) | 2022 | 35402469 | PubTator, text mining | PubMed |
| Identification of potential target genes in Homo sapiens, by miRNA of Triticum aestivum: A cross kingdom computational approach. | Noncoding RNA Res | 2022 | 35387280 | PubTator, text mining | PubMed |
| Influence of carrier materials and coatings on retinal pigment epithelium cultivation and functions. | Exp Eye Res | 2022 | 35385758 | PubTator, text mining | PubMed |
| VEGFA-targeting miR-agshRNAs combine efficacy with specificity and safety for retinal gene therapy. | Mol Ther Nucleic Acids | 2022 | 35356684 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7439/papers?page=18